PremiumCompany AnnouncementsSinovac Biotech Delays Annual Report Filing Sinovac Biotech issues shareholder letter regarding Vivo Capital claims Sinovac Biotech board issues shareholder letter regarding Vivo Capital claims PremiumCompany AnnouncementsSinovac Biotech Declares Special Cash Dividend Amid Board Review Sinovac Biotech to declare $55.00 per share special cash dividend Sinovac Biotech Strengthens Board with New Appointment PremiumThe FlySinovac issues statement regarding privy council judgment Sinovac Biotech initiates clinical trial on a HFMD vaccine candidate Sinovac Biotech Experiences 2024 Mid-Year Downturn